| Literature DB >> 33525977 |
Grant S Nolan1, Oliver J Smith1, Gavin Jell1, Afshin Mosahebi1.
Abstract
Stem cells could form the basis of a novel, autologous treatment for chronic wounds like diabetic foot ulcers. Fat grafts contain adipose-derived stem cells (ADSC) but low survival of cells within the grafts is a major limitation. Platelet-rich plasma (PRP) may increase graft survival. This review examines the histology from animal studies on fat grafting, ADSC and PRP in wound healing. A literature review of major electronic databases was undertaken, and narrative synthesis performed. Data from 30 animal studies were included. ADSC increase angiogenesis over 14 days and often clinically accelerated wound healing. ADSC had a greater effect in animals with impaired wound healing (e.g. diabetes). Activated PRP increased viability of fat grafts. Despite the high number of studies, the quality is variable which weakens the evidence. It does suggest there is a benefit of ADSC, particularly in impaired wound healing. High-quality evidence in humans is required, to establish its clinical usefulness.Entities:
Keywords: Adipose-derived stem cells; diabetic foot ulcer; fat grafting; mesenchymal stem cells; platelet-Rich Plasma; wound healing
Year: 2021 PMID: 33525977 PMCID: PMC7872055 DOI: 10.1080/21623945.2021.1876374
Source DB: PubMed Journal: Adipocyte ISSN: 2162-3945 Impact factor: 4.534